GLI1 and breast carcinoma: Once genistein inhibits the Hedgehog-Gli1 signaling pathway, breast cancer cells undergo cell death by downregulating the proteins SMO and/or Gli1, which eventually impede the cancer stem cell survival pathway, it also limits the proliferation of BCSCs and lowers the endurance of cancer stem cells (CSCs).